Search results for "alcohol withdrawal"

showing 10 items of 10 documents

Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence

2002

Abnormalities in monoamine neurotransmission have been implicated in the pathogenesis of alcoholism, mood disorders and schizophrenia. Murine norepinephrine transporter gene (NET) has been mapped to a region on chromosome 8 where a quantitative trait locus for ethanol sensitivity. Therefore we tested whether norepinephrine transporter (NET) gene variants confer susceptibility to either alcohol dependence or severe alcohol withdrawal symptoms. There is a highly polymorphic silent G1287A mutation in the NET gene. In our study 157 alcoholics and 185 healthy unrelated matched control subjects were analyzed for a silent G1287A mutation. No significant differences in allele and genotype distribut…

AdultMalemedicine.medical_specialtyGenotypeDNA Mutational AnalysisMolecular Sequence DataAlcohol Withdrawal DeliriumGene FrequencyPolymorphism (computer science)Internal medicineGenotypemedicineHumansGenetic Predisposition to DiseaseRNA MessengerAlleleAllelesBiological PsychiatryGeneticsNorepinephrine Plasma Membrane Transport ProteinsPolymorphism GeneticSymportersbiologybusiness.industryAlcohol dependenceExonsMiddle Agedmedicine.diseaseAlcoholismPsychiatry and Mental healthMonoamine neurotransmitterEndocrinologyMood disordersNorepinephrine transporterbiology.proteinFemaleGene polymorphismbusinessPolymorphism Restriction Fragment LengthPsychiatry Research
researchProduct

Association of a CB1 Cannabinoid Receptor Gene (CNR1) polymorphism with severe alcohol dependence

2002

Abstract Due to the involvement of the endogenous cannabinoid system in brain reward mechanisms a silent polymorphism (1359G/A; Thr453Thr) in the single coding exon of the CB1 human cannabinoid receptor gene ( CNR1 ) was analysed in 121 severely affected Caucasian alcoholics and 136 most likely non-alcoholic controls. The observed frequency of the A allele was 31.2% for controls and 42.1% for alcoholics with severe withdrawal syndromes ( P =0.010). Post-hoc exploration indicated that this allelic association resulted from an excess of the homozygous A/A genotype in patients with a history of alcohol delirium ( P =0.031, DF 2), suggesting s an increased risk of delirium (OR=2.45, 95% CI 1.14…

Adultmedicine.medical_specialtyCannabinoid receptorGenotypeReceptors DrugToxicologyAlcohol Withdrawal SeizuresAlcohol Withdrawal DeliriumExonRisk FactorsPolymorphism (computer science)Internal medicinemental disordersGenotypemedicineHumansPharmacology (medical)AlleleReceptors CannabinoidPharmacologyPolymorphism Geneticbusiness.industryAlcohol Withdrawal DeliriumAlcoholismPsychiatry and Mental healthEndocrinologyDeliriumBrain stimulation rewardmedicine.symptombusinessDrug and Alcohol Dependence
researchProduct

Sodium oxybate therapy for the treatment of alcohol withdrawal syndrome and the maintenance of alcohol abstinence

2017

Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal.

gamma-hydroxybutyrateGHB; alcohol abstinence.; alcohol withdrawal; gamma-hydroxybutyrate; gamma-hydroxybutyric acid; sodium oxybateSettore MED/43 - Medicina Legalealcohol abstinence.alcohol withdrawalgamma-hydroxybutyric acidSettore BIO/14 - FarmacologiaGHBsodium oxybate
researchProduct

Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit.

2001

Abstract Objective. Alcohol withdrawal syndrome (AWS) is a serious complication during postoperative treatment in chronic alcoholics. Despite prophylactic treatment, AWS occurs in at least 25% of these patients after elective surgery. An established protocol for the prevention of AWS is ethanol administration. The aim of this study was to evaluate possible differences in ethanol dose and levels between successfully treated patients and those who developed AWS. Design. Prospective, observational study with retrospective post hoc analysis. Setting. Intensive care unit (ICU). Patients. Thirty-two alcohol-dependent patients undergoing elective or emergency surgery after trauma with postoperativ…

medicine.medical_specialtyCritical Care and Intensive Care Medicinelaw.inventionlawAnesthesiologyGermanyPost-hoc analysisOutcome Assessment Health CaremedicineHumansProspective StudiesElective surgeryProspective cohort studyMonitoring PhysiologicRetrospective StudiesEthanolbusiness.industryRetrospective cohort studyVenous bloodmedicine.diseaseIntensive care unitSubstance Withdrawal SyndromeAlcoholismIntensive Care UnitsAlcohol withdrawal syndromeAnesthesiaSurgical Procedures OperativeWounds and InjuriesbusinessIntensive care medicine
researchProduct

Alcohol-related seizures may be associated with more severe depression, alcohol dependence syndrome, and more pronounced alcohol-related problems.

2018

Severe alcohol abuse and related medical and social functioning risks, as well as clinically significant depression, are common in patients who are admitted to hospital with alcohol-related seizures (ARS) and significantly affect the quality of life of the patient. Compared with studies involving patients with alcohol dependence, no large-scale studies with the aim of finding the prevalence and severity of depression and its most commonly affected aspects for patients with ARS have been carried out in Latvia yet. The habits and frequency of alcohol use in correlation to depression and its severity are also not known. One hundred ten patients were included in the study - 60 patients with ARS…

AdultMalemedicine.medical_specialtyAlcohol DrinkingPopulationAlcohol abuseAlcohol use disorderAffect (psychology)Severity of Illness IndexAlcohol Withdrawal SeizuresSuicidal Ideation03 medical and health sciencesBehavioral NeuroscienceEpilepsy0302 clinical medicinemedicineHumans030212 general & internal medicinePsychiatryeducationDepression (differential diagnoses)Agededucation.field_of_studyAlcohol Use Disorders Identification Testbusiness.industryDepressionAlcohol dependenceMiddle Agedmedicine.diseaseAlcoholismCross-Sectional StudiesNeurologyQuality of LifeFemaleNeurology (clinical)business030217 neurology & neurosurgeryEpilepsybehavior : EB
researchProduct

Genome-wide Association Study of Alcohol Dependence

2009

Context Alcohol dependence is a serious and common public health problem. It is well established that genetic factors play a major role in the development of this disorder. Identification of genes that contribute to alcohol dependence will improve our understanding of the mechanisms that underlie this disorder. Objective To identify susceptibility genes for alcohol dependence through a genome-wide association study (GWAS) and a follow-up study in a population of German male inpatients with an early age at onset. Design The GWAS tested 524 396 single-nucleotide polymorphisms (SNPs). All SNPs with P −4 were subjected to the follow-up study. In addition, nominally significant SNPs from genes t…

AdultGenetic MarkersMaleGenotypeGenetic LinkagePopulationContext (language use)Single-nucleotide polymorphismGenome-wide association studyBiologyPolymorphism Single NucleotideGenetic determinismArticleAlcohol Withdrawal DeliriumYoung AdultArts and Humanities (miscellaneous)Genetic linkageAnimalsHumansAlleleAge of OnseteducationAllelesGeneticseducation.field_of_studyGene Expression ProfilingAlcohol dependenceAlcohol DehydrogenasePutamenRats Inbred StrainsAmygdalaCadherinsRatsHospitalizationPsychiatry and Mental healthAlcoholismPhenotypeGene Expression RegulationCase-Control StudiesChromosomes Human Pair 2Caudate NucleusLod ScoreFollow-Up StudiesGenome-Wide Association Study
researchProduct

Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence

2018

BACKGROUND Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal. OBJECTIVE The aim of the present review was to describe the state of art of the pre-clinical research and the clinical evidence related to GHB used alone or in combination with other treatments in alcohol withdrawal syndrome and alcohol abstinence maintenance. METHOD Internationally published pre-clinical findings and clinical studi…

medicine.medical_specialtySodium Oxybatemedia_common.quotation_subjectClinical Biochemistry01 natural sciencesNaltrexone03 medical and health sciences0302 clinical medicinemedicineHumansmedia_common.cataloged_instance030216 legal & forensic medicineEuropean unionPsychiatrymedia_commonPharmacologyAlcohol Abstinencebusiness.industry010401 analytical chemistryGamma hydroxybutyrategamma-Hydroxybutyric acidAbstinencemedicine.diseaseSubstance Withdrawal Syndrome0104 chemical sciencesAlcohol withdrawal syndromeSodium OxybatebusinessAlcohol-Related DisordersCentral Nervous System AgentsAlcohol Abstinencemedicine.drugCurrent Drug Metabolism
researchProduct

Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent.

1998

A decreased basal and/or stimulated activity of the G-protein/adenylyl cyclase (AC) system in peripheral blood cells has been proposed to represent a trait marker for alcoholism. However, AC activity may underlie state-dependent changes, which may impair a proper interpretation of AC activity measurements. Our study examined systematically the AC activity in peripheral lymphocytes of 73 male alcohol-dependent patients (according to DSM-IV criteria) at three different time points of measurement during the clinical course of detoxification (day 0 = at admission, while still ethanol-affected; day 2 = at the presumed peak of withdrawal symptoms; day E = after detoxification). Basal and stimulat…

AdultMalemedicine.medical_specialtyLymphocyteGTPgammaSMedicine (miscellaneous)ToxicologyAdenylyl cyclaseAlcohol Withdrawal Deliriumchemistry.chemical_compoundBasal (phylogenetics)Reference ValuesInternal medicineDetoxificationmedicineHumansLymphocytesAgedForskolinbusiness.industryMiddle AgedPeripheralPsychiatry and Mental healthAlcoholismmedicine.anatomical_structureEndocrinologychemistryToxicitybusinessBiomarkersAdenylyl CyclasesAlcoholism, clinical and experimental research
researchProduct

Reliability and validity of the form 90 interview.

2004

<i>Objective:</i> Alcohol consumption is a central variable in substance abuse research and treatment. The study reports the psychometric characteristics of the German version of the Form 90 interview for the assessment of recent alcohol consumption. <i>Method:</i> Reliability was evaluated in a test-retest study (7 days) with 30 consecutively admitted psychiatric inpatients with alcohol dependence. Validity of Form 90 was assessed with a second sample of 60 alcohol-dependent inpatients. <i>Results:</i> Form 90 demonstrated good to excellent retest reliability for the central variables of alcohol consumption. Retest reliability Pearson correlation coeffic…

AdultMaleHealth (social science)Alcohol DrinkingPsychometricsIntraclass correlationSubstance-Related DisordersTemperanceStatistics as TopicMedicine (miscellaneous)AlcoholComorbidityMedical RecordsAlcohol Withdrawal Deliriumchemistry.chemical_compoundsymbols.namesakeGermanyInterview PsychologicalmedicineHumansReliability (statistics)Mental DisordersAlcohol dependenceReproducibility of ResultsMiddle Agedmedicine.diseaseConfidence intervalPearson product-moment correlation coefficientSubstance abuseHospitalizationPsychiatry and Mental healthAlcoholismchemistryStructured interviewsymbolsPatient ComplianceFemalePsychologyClinical psychologyFollow-Up StudiesEuropean addiction research
researchProduct

Development of a rating scale for quantitative measurement of the alcohol withdrawal syndrome

1992

The alcohol withdrawal syndrome consists of autonomic, neurological and mental symptoms. For its assessment, these symptoms have to be rated in a quantitative and valid manner. We developed a new rating scale for mild and moderate alcohol withdrawal states. Difficulty, discrimination coefficient, internal consistency, and the principal component analysis were assessed. External validation was tested on a separate sample of inpatients. Eight of 12 original items fulfilled test-the-oretical criteria. From these a psychosensory and an autonomic factor have been extracted. This instrument can be used repeatedly for clinical assessment as well as for evaluation of the alcohol withdrawal syndrome…

AdultMalemedicine.medical_specialtyPsychometricsPsychometricsSeparate sampleTest validityAlcohol Withdrawal DeliriumRating scaleInternal consistencymedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryNeurologic ExaminationMental symptomsExternal validationGeneral MedicineMiddle Agedmedicine.diseaseAlcoholismPsychiatry and Mental healthAlcohol withdrawal syndromeFemalePsychologyClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct